Researchers determine the efficacy and safety of azelastine nasal spray for preventing SARS-CoV-2 infection in healthy adults.

A common hay fever nasal spray was found to cut COVID-19 infections by two-thirds in a clinical trial, while also reducing rhinovirus cases. Researchers believe it could serve as an easy, low-cost preventive measure, pending further studies.